An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.

Summary

This extension study will allow participants to continue receiving treatment with HGT-1410 and to initiate treatment in patients who received no-treatment in Study HGT-SAN-093, and will evaluate the long-term safety and efficacy of the study drug.

Timeline

Start

2015-04-08

Primary completion

2019-04-12

Completion

2019-04-12

Outcome

Outcome not reported

Stopped: “Completion of follow-up period”

Drugs

Indications